Neutral impactResults
Natco Pharma Q2 Results: Net profit and revenue decline from last year; declares dividend
CNBC-TV18 21 min ago·13 Nov 2026, 9:10 am
Natco Pharma reported a decline in both net profit and revenue for the second quarter compared to the previous year. Despite this, the company has announced a second interim dividend of ₹1.25 per equity share, which translates to a payout of 62.5% on the face value of ₹2 per share. This dividend is for the financial year 2027. The record date to determine eligible shareholders is set for November 19.
This development is significant for investors as it provides a steady return on their investment through dividends, even as the company's core business performance has weakened. The payout ratio indicates a substantial portion of earnings is being returned to shareholders. Investors should monitor the company's future earnings reports to see if the dividend is sustainable given the recent dip in financial results.
Excerpt from CNBC-TV18
Published On Nov 13, 2026 | 14:40 IST Last Updated On Nov 13, 2026 | 14:40 IST Natco Pharma has declared a second interim dividend of ₹1.25 per equity share, representing a payout of 62.5% on the face value of ₹2 per share, for FY27. The company has fixed November 19 as the record date to determine shareholders…Read the original at CNBC-TV18
Affected stocks
Neutral1 stock
Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns Natco Pharma (NATCOPHARM).
- Category: Results.
Why it matters
A routine update for Natco Pharma. Use the price and stock snapshot to gauge how the market is responding.
